Roxithromycin

Phispers: Pfizer-Allergan end megamerger, GSK wants to make copying its drugs easier & more

This week, the biggest news in the world of pharmaceuticals was the termination of the Pfizer-Allerg

Niche European Molecules: is there a business opportunity worth pursuing?

New drug development is a series of complex activities invariably involving tremendous financial in